Showing results (621-630 of 1,813) with videos related to

Sort By:
Pageof 182
Transplantation and Cellular Therapy|August 24, 2020
Comparison of 2 Different Rabbit Anti-Thymocyte Globulin (r-ATG) Preparations: Thymocyte r-ATG versus T Lymphoblast Cell Line r-ATG in Allogeneic Hematopoietic Stem Cell Transplantation for Acquired Severe Aplastic Anemia: Propensity Score-Matched AnalysisLimin Liu, Guofa Xu, Yanming Zhang, et al.
Transplantation and Cellular Therapy|April 23, 2021
Risk Factors for Mortality in Hematopoietic Stem Cell Transplantation Recipients with Bloodstream Infection: Points To Be Addressed by Future GuidelinesPedro Puerta-Alcalde, Mariana Chumbita, Paola Charry, et al.
Transplantation and Cellular Therapy|April 25, 2021
COVID-19 and Hematopoietic Cell Transplantation Center-Specific Survival Analysis: Can We Adjust for the Impact of the Pandemic? Recommendations of the COVID-19 Task Force of the 2020 Center for International Blood and Marrow Transplantation Research Center Outcomes ForumJohn R Wingard, Kwang Woo Ahn, Christopher Dandoy, et al.
Transplantation and Cellular Therapy|April 25, 2021
Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United StatesNeel S Bhatt, Ruta Brazauskas, Rachel B Salit, et al.
Transplantation and Cellular Therapy|April 25, 2021
Hematopoietic Cell Transplantation Outcomes among Medicaid and Privately Insured Patients with Sickle Cell DiseaseTatenda G Mupfudze, Christa Meyer, Jaime M Preussler, et al.
Transplantation and Cellular Therapy|March 29, 2023
Impact of Donor Age in Haploidentical-Post-Transplantation Cyclophosphamide versus Matched Unrelated Donor Post-Transplantation Cyclophosphamide Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid LeukemiaRohtesh S Mehta, Jeremy Ramdial, David Marin, et al.
Transplantation and Cellular Therapy|April 1, 2023
A Pilot Trial of Patient-Reported Outcomes for Acute Graft-Versus-Host-DiseaseSagar S Patel, Sanghee Hong, Lisa Rybicki, et al.
Transplantation and Cellular Therapy|April 25, 2023
Prospective Study of a Modified Post-Transplantation Cyclophosphamide Regimen for Severe Aplastic Anemia Patients with HLA-Haploidentical TransplantationLiangliang Wu, Ming Zhou, Yumiao Li, et al.
Transplantation and Cellular Therapy|April 10, 2021
Characterizing Immune-Mediated Cytopenias After Allogeneic Hematopoietic Cell Transplantation for Pediatric Nonmalignant DisordersRobert T Galvin, Qing Cao, Weston P Miller, et al.
Transplantation and Cellular Therapy|April 10, 2021
Multicenter Phase II Study on Haploidentical Bone Marrow Transplantation Using a Reduced-Intensity Conditioning Regimen and Posttransplantation Cyclophosphamide in Patients with Poor-Prognosis LymphomasLuca Castagna, Anna Dodero, Francesca Patriarca, et al.
Pageof 182